Ashwin Srinivasan Kumar

10PUBLICATIONS
61CO-AUTHORS
Molecular targetsSolid tumoursBiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2025
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma.

Shanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar

|Jun 11, 2025
Solid Stress Estimations via Intraoperative 3D Navigation in Patients with Brain Tumors.

Hadi T Nia, Meenal Datta, Ashwin S Kumar

|Mar 26, 2024
Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits.

Meenal Datta, Laura E Via, Véronique Dartois

|Jun 21, 2023
Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes.

Pin-Ji Lei, Ethel R Pereira, Patrik Andersson

|Feb 07, 2023
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer.

Yves Boucher, Jessica M Posada, Sonu Subudhi

|Feb 01, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.

Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez

Pageof 2